Post-approval studies (Phase 4)Ended earlyNCT00972543What this trial is testingRaptiva in Palm and Sole PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 6
Very early researchEnded earlyNCT01317017What this trial is testingCell Responses to IFN-gammaWho this might be right forPlaque Psoriasis Rockefeller University 2
Not applicableStudy completedNCT04433442What this trial is testingStudy to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisWho this might be right forPsoriasisPsoriatic Arthritis AbbVie 2,324
Testing effectiveness (Phase 2)Study completedNCT03381625What this trial is testingTopical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque PsoriasisWho this might be right forPsoriasisAtopic Dermatitis BioMimetix JV, LLC 139
Post-approval studies (Phase 4)Study completedNCT00493324What this trial is testingStudy to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Astellas Pharma Inc 43
Testing effectiveness (Phase 2)Ended earlyNCT02201524What this trial is testingStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Pfizer 59
Not applicableStudy completedNCT06011083What this trial is testingTopical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque PsoriasisWho this might be right forPsoriasis VulgarisFractional CO2 Laser Assiut University 40
Testing effectiveness (Phase 2)Study completedNCT02785159What this trial is testingSafety and Efficacy of IDP-118 Lotion in the Treatment of Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 152
Testing effectiveness (Phase 2)Study completedNCT01607853What this trial is testingA Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis VulgarisWho this might be right forPsoriasis Vulgaris LEO Pharma 24
Post-approval studies (Phase 4)Study completedNCT00932113What this trial is testingMechanism of Action Study for PsoriasisWho this might be right forPsoriasis Tufts Medical Center 33
Early research (Phase 1)UnknownNCT02918123What this trial is testingSafety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Kang Stem Biotech Co., Ltd. 9
Post-approval studies (Phase 4)Study completedNCT00990561What this trial is testingComparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of PsoriasisWho this might be right forStable Plaque Psoriasis University of California, San Francisco 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541What this trial is testingLong-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisPsoriasis (PsO)Psoriasis+2 more Alumis Inc 1,680
Testing effectiveness (Phase 2)Study completedNCT01901705What this trial is testingTopical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type PsoriasisWho this might be right forPsoriasis China Medical University Hospital 24
Testing effectiveness (Phase 2)Study completedNCT01119339What this trial is testingStudy to Investigate Dose-related Efficacy of LAS41004 in the Treatment of PsoriasisWho this might be right forPsoriasis Almirall, S.A. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT01228656What this trial is testingEffectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone FuroateWho this might be right forPlaque Psoriasis Azidus Brasil 40
Testing effectiveness (Phase 2)Study completedNCT00770965What this trial is testingPhase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 80
Post-approval studies (Phase 4)Study completedNCT02340169What this trial is testingAdrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque PsoriasisWho this might be right forPlaque Psoriasis Sun Pharmaceutical Industries, Inc. 129
Large-scale testing (Phase 3)Study completedNCT05919082What this trial is testingInvestigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque PsoriasisWho this might be right forStable Plaque Psoriasis LEO Pharma 604
Testing effectiveness (Phase 2)Study completedNCT04718896What this trial is testingAssess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis UCB Biopharma SRL 41